Introduction {#s1}
============

The use of optical coherence tomography (OCT) in clinical practice has revealed that various types of abnormal vessel reactions associated with stent implantation (stent malapposition, thrombus, prolapse, and edge dissection) develop more frequently than expected.^[@JES299C1],[@JES299C2]^ Given the high incidence of these abnormalities after treatment with the currently available metallic stents and the possible link between such phenomena and future clinical events, elucidation of the natural course of these findings is important regarding the safety and cost-effectiveness of percutaneous coronary intervention (PCI), because such information might help avoid unnecessary additional procedures frequently performed after stent implantation to achieve stent optimization.

In this context, several investigators including our group have reported that high-resolution OCT allows for visualization of microstructural abnormal findings before and after PCI when compared with the current gold standard, intravascular ultrasound (IVUS).^[@JES299C2]^ In the present study, we performed a serial OCT examination to clarify the natural course of minor abnormalities, such as stent malapposition, thrombus, prolapse, and edge dissection.

Methods {#s2}
=======

Study population and methods {#s2a}
----------------------------

Study subjects were collected from among patients who provided written informed consent for OCT-guided PCI and follow-up OCT examination. We retrospectively selected patients implanted with sirolimus-eluting stents (SES: Cypher^TM^, Cordis Corp., Miami Lakes, FL, USA) or paclitaxel-eluting stents (PES: Taxus Liberte^TM^, Boston Scientific Corp., Natick, MA, USA) having excellent OCT images immediately after stent implantation and at the 8-month follow-up. A total of 35 stable or unstable angina patients treated with SES or PES were enrolled into this study from December 2007 to September 2010. Inclusion criteria for this study were as follows: (i) native coronary arteries with diameter stenosis ≥75% and (ii) reference vessel diameter between 2.5 and 3.5 mm based on visual estimation. Exclusion criteria were as follows: (i) acute myocardial infarction, (ii) apparent congestive heart failure, (iii) contraindication to dual antiplatelet therapy, and (iv) lesions unsuitable for OCT (severe tortuous lesions and ostial lesions). All the patients were taking aspirin (100 mg/day). Ticlopidine (200 mg/day), or clopidogrel (75 mg/day) was also given for at least 8 months after stent implantation. The study was approved by the Ethics Committee of Kobe University and all enrolled study patients provided their written informed consent.

OCT examination {#s2b}
---------------

In this study, as frequency-domain OCT had not been approved for clinical use in Japan during the study period, time-domain OCT with coronary artery occlusion was used as previously reported.^[@JES299C3]^

OCT analysis {#s2c}
------------

All images were analysed by an independent observer who was blinded to the clinical presentations and lesion characteristics. Cross-sectional OCT images were analysed at every frame. Bifurcation lesions with major side branches were excluded from the analysis. To obtain identical analysis of segments at baseline and at follow-up OCT, we displayed the baseline and follow-up OCT images side-by-side and performed serial OCT analysis using information about the motorized pullback speed and landmarks such as the presence of calcium deposits, side branches, and plaque shape.

For qualitative analysis, we evaluated the presence of stent malapposition, thrombus, tissue prolapse, and stent edge dissection. Stent malapposition was defined as the distance between the centre reflection of the strut and the vessel wall greater than the actual stent thickness plus the OCT resolution limit. This resulted in stent malapposition thresholds of ≥170 µm for SES and ≥140 µm for PES.^[@JES299C3]^ The malapposition length was defined as the number of consecutive frames with malapposed struts. We evaluated the maximum malapposition length for every stent. Malapposition identified after stent implantation but absent at follow-up was defined as resolved; otherwise, it was persistent. If both resolved and persistent malapposition were existed within the same stent on follow-up OCT images, it was defined as partially resolved stents. Late-acquired malapposition was defined as that not present immediately after the procedure but observed at the follow-up.^[@JES299C4]^

Intracoronary thrombus was defined as a mass protruding beyond the stent strut into the lumen with significant attenuation behind the mass.^[@JES299C5],[@JES299C6]^ Resolved thrombus was defined as that observed after stent implantation, but absent at the follow-up. Persistent thrombus was defined as that still present during the follow-up period. Late-acquired thrombus was defined as that not present after the procedure, but newly appearing at the follow-up. Tissue prolapse was defined as a protrusion of tissue between the stent struts, extending inside a circular arc connecting adjacent struts in both OCT images.^[@JES299C7]^ Stent edge dissection was defined as disruption of the luminal vessel surface in the edge segments.^[@JES299C7]^ Representative serial OCT images of these figures are shown in *Figure [1](#JES299F1){ref-type="fig"}*. Figure 1Representative OCT images: (*A*) classification of malapposed struts: (a) resolved malapposition, (b) persistent malapposition, (c) late-acquired malapposition, (*B*) classification of thrombus: (a) resolved thrombus, (b) persistent thrombus, (c) late-acquired thrombus, (*C*) tissue prolapse, (*D*) edge dissection.

For quantitative analysis, the neointimal thickness inside each stent strut was measured for all malapposed struts. Also, we calculated the incidence of frames with malapposed struts, thrombus, and tissue prolapse on baseline and follow-up OCT images (number of frames with malapposed struts, thrombus, prolapse/total number of frames) to evaluate the changes in the longitudinal length of these abnormalities during the follow-up.

Clinical follow-up {#s2d}
------------------

The incidence of death, myocardial infarction, target lesion revascularization (TLR), and stent thrombosis was evaluated 8 months after the index stent procedure. TLR was defined as any reintervention (surgical or percutaneous) to treat restenosis of the analysed segment.

Statistical analysis {#s2e}
--------------------

All statistical analyses were performed using the StatView 5.0 software (SAS Institute, Inc., Cary, NC, USA). Qualitative data are expressed as frequencies, and quantitative data are shown as mean values ± SD. Continuous variables were compared using an unpaired or paired Student\'s *t*-test or Mann--Whitney *U* test. Differences in categorical variables were assessed using the *χ*^2^ test and Fisher\'s exact tests. We performed a ROC analysis of the S--V distance to identify the optimal cut-off value for predicting the natural course of malapposed struts during the follow-up (resolved or persistent) using Medcalc (MedCalc Software, Mariakerke, Belgium). For all comparisons, a *P*-value \<0.05 was considered statistically significant.

Results {#s3}
=======

Baseline patient demographic, lesion, and procedural characteristics are shown in *Tables [1](#JES299TB1){ref-type="table"}* and [2](#JES299TB2){ref-type="table"}. In all stents, angiographic optimization was accomplished after PCI. Table 1Baseline patient characteristicsVariable35 patients (40 stents)Age65.3 ± 10.3Men (%)28 (80)Hypertension (%)24 (68)Dyslipidaemia (%)26 (74)Cigarette smoking (%)17 (49)Diabetes (%)19 (54)Renal dysfunction (%)7 (20)Prior myocardial infarction (%)3 (9)Prior PCI (%)8 (23)Prior CABG (%)0 (0)Clinical presentation (%) Stable angina pectoris33 (94) Unstable angina pectoris2 (6)Statin24 (69)ACE-I, ARB22 (63)[^1][^2] Table 2Procedural characteristicsVariable35 patients (40 stents)Location, proximal/mid/distal8/27/5ACC/AHA classification, type A/type B/type C3/31/6Stent type Cypher™19 Taxus Liberte™21Average stent diameter (mm)3.0 ± 0.4Average stent length (mm)21.9 ± 7.0Multiple overlapping stents2Multivessel stenting3Stent implantation pressure (atm)10.8 ± 2.1Post-dilatation23Largest balloon size for dilatation (mm)3.2 ± 0.4Maximum inflation pressure (atm)13.8 ± 3.2Angiographically detected dissection0Follow-up duration (month)8.1 ± 1.5[^3][^4]

Incidence of persistent, resolved, and late-acquired stent malapposition {#s3a}
------------------------------------------------------------------------

Stent malapposition was observed in 65.0% of enrolled stents (26/40 stents) immediately after stenting, and in 32.5% (13/40 stents) at the follow-up (*Figure [2](#JES299F2){ref-type="fig"}A*). Among a total of 26 stents with post-procedural malapposition, serial OCT analysis revealed that 6 stents (6/26: 23.1%) were partially resolved with at least one persistent malapposed strut at the follow-up, and 20 stents (20/26: 76.9%) were completely resolved without any malapposed struts observed on the follow-up OCT images (*Figure [2](#JES299F2){ref-type="fig"}A*). Late-acquired malapposition was observed in seven stents (7/40; 17.5%). According to strut-based analysis, 431 struts among a total of 73 929 struts (0.58%) were malapposed on post-procedural OCT images. Among these, serial OCT analysis revealed persistent malapposition of 49 struts, but the other 382 struts had resolved during the follow-up (resolved malapposition), and there were 108 newly appearing malapposed struts at the follow-up (late-acquired malapposition). Figure 2Number of abnormal findings after stenting: (*A*) stent malapposition, (*B*) thrombus, (*C*) tissue prolapse, (*D*) edge dissection.

In most of the stents with malapposed struts after PCI, the maximum malapposition length was equal to or less than five cross-sections (*Table [3](#JES299TB3){ref-type="table"}*). The incidences of cross-sections with malapposed struts decreased from post-procedure to the follow-up (*Table [4](#JES299TB4){ref-type="table"}*). Table 3Malapposition length analysisMaximum malapposition lengthAfter PCIAt follow-up≤5 cross-sections19 stents9 stents6 ≤ 15 cross-sections5 stents3 stents≥16 cross-sections2 stents1 stent Table 4Cross-sectional OCT analysisVariableImmediately after PCIFollow-up*P*-valueStent malapposition231 cross-sections2.04%117 cross-sections0.97%0.054Thrombus488 cross-sections5.10%108 cross-sections0.89%0.021Tissue prolapse3141 cross-sections28.17%0 cross-section0.00%\<0.01

Relation between neointimal coverage and natural course of malapposed struts {#s3b}
----------------------------------------------------------------------------

The extent of the strut coverage among the different types of malapposition differed significantly (*Figure [3](#JES299F3){ref-type="fig"}*). The incidence of uncovered struts was significantly higher among late-acquired and persistent malapposed struts compared with resolved malapposed struts. Additionally, the mean neointimal thickness of resolved malapposed struts was significantly greater than that of the persistent and late-acquired malapposed struts. Figure 3The frequency of neointimal coverage and the measurement of neointimal thickness between resolved malapposed struts, persistent malapposed struts, and late-acquired malapposed struts: (*A*) the incidence of struts without neointima was significantly higher in late-acquired and persistent malapposed struts compared with resolved malapposed struts. (*B*) The mean neointimal thickness of resolved malapposed struts was significantly thicker than that of the persistent and late-acquired malapposed struts.

Relation between S--V distance and natural course of malapposed struts {#s3c}
----------------------------------------------------------------------

The mean S--V distance for all malapposed struts on post-procedural OCT images was 224 ± 71 μm. The mean post-procedural S--V distance of persistent malapposed struts was significantly greater than that of resolved malapposed struts (342 ± 99 μm vs. 210 ± 49 μm; *P \<*0.01). Based on the ROC analysis, an S--V distance ≤260 µm was the corresponding cut-off point for a resolved malapposed strut with a maximum sensitivity of 89.3% and a specificity of 83.7% \[area under the curve (AUC) = 0.884\]. Indeed, most malapposed struts with an S--V distance ≤260 μm (341/349 struts; 97.7%) were observed to be well-apposed on follow-up OCT images (*Figure [4](#JES299F4){ref-type="fig"}*). Only eight struts with an S--V distance ≤260 μm (8/349 struts; 2.3%) persisted, and all were observed in the same stent with suspicious plaque regression or thrombus dissolution (*Figure [5](#JES299F5){ref-type="fig"}*). Figure 4ROC curve analysis and distribution of S--V distance of post-procedural malapposed struts. (*A*) An S--V distance ≤260 µm was the corresponding cut-off point for a resolved malapposed strut with a maximum sensitivity of 89.3% and a specificity of 83.7% (AUC = 0.884, *P* = 0.001). (*B*) Only eight struts with an S--V distance ≤260 μm persisted. Figure 5A case of persistent malapposed struts with a baseline S--V distance ≤260 μm: left panel shows the OCT image immediately after Taxus Liberte™ implantation. The S--V distance is 180 μm, which is less than the cut-off value of the S--V distance of 260 μm. These malapposed struts persisted on follow-up OCT images (right panel), probably due to plaque regression or thrombus dissolution.

Serial OCT analysis of thrombus, tissue prolapse, and edge dissection {#s3d}
---------------------------------------------------------------------

Thrombus was observed in 15 stents (15/40: 37.5%) post-PCI and in 8 stents (8/40: 20%) at the follow-up. Serial OCT analysis revealed persistent thrombus in 1 stent (1/15: 6.7%), resolved thrombus in 14 stents (14/15: 93.3%), and late-acquired thrombus in 8 stents (8/40: 20%) (*Figure [2](#JES299F2){ref-type="fig"}B*). Tissue prolapse was observed in 95% cases (38/40 stents) immediately after PCI, and was not observed in any of the cases at the 8-month follow-up examination (*Figure [2](#JES299F2){ref-type="fig"}C*). There were eight stents with edge dissections immediately after PCI, all of which were repaired at the follow-up (*Figure [2](#JES299F2){ref-type="fig"}D*). The incidences of cross-sections with thrombus and tissue prolapse decreased from post-procedure to the follow-up (*Table [4](#JES299TB4){ref-type="table"}*).

Comparison between sirolimus-eluting stents and paclitaxel-eluting stents {#s3e}
-------------------------------------------------------------------------

The percentage of malapposed struts after PCI was 0.45% (128/27843 struts) in SES, and 0.66% (303/46086 struts) in PES. On the basis of the ROC curve analysis according to the stent type, we identified an S--V distance ≤280 µm as the best cut-off point for a resolved malapposed strut with a maximum sensitivity of 95.0% and a specificity of 100% for SES (AUC: 0.991), and an S--V distance ≤260 µm for PES (sensitivity 87.8%, specificity 80.0%, AUC = 0.865; *Figure [6](#JES299F6){ref-type="fig"}*). The AUC for SES was numerically higher than that of PES. The incidence of thrombus, edge dissection, and tissue prolapse did not differ between SES and PES. Figure 6Comparison of ROC curve analysis and distribution of S--V distance between SES and PES: (*A*) SES; an S--V distance of ≤280 was the best cut-off point for a resolved malapposed strut with a maximum sensitivity of 95.0% and a specificity of 100% (AUC: 0.991). All the malapposed struts with an S--V distance ≤280 μm changed to be well-apposed. (*B*) PES; an S--V distance of ≤260 was the best cut-off point for a resolved malapposed strut (sensitivity 87.8%, specificity 80.0%, AUC = 0.865). Eight malapposed struts with S--V distance ≤260 μm persisted.

Clinical outcome {#s3f}
----------------

There were no deaths at the 8-month follow-up. One patient had myocardial infarction at another vessel occlusion. TLR was necessary in six patients with seven stents. Malapposition, thrombus, tissue prolapse, and edge dissection on post-stenting OCT images were not associated with the rate of TLR at the 8-month clinical follow-up. Stent thrombosis did not occur during the follow-up (*Table [5](#JES299TB5){ref-type="table"}*). Table 5Clinical Outcome at 8-monthVariable*n* = 35Death (%)0 (0)Myocardial infarction (%)1 (2.9)Target lesion revascularization (%)6 (17.1)Stent thrombosis (%)0 (0)

Discussion {#s4}
==========

The findings of the present study demonstrated the following: (i) despite a relatively high incidence of post-procedural stent malapposition (65%), \>70% of such malapposed stents had completely resolved during the follow-up period; (ii) resolved malapposed struts had a significantly thicker neointima together with fewer incidences of uncovered struts than persistent and late-acquired malapposed struts; (iii) an S--V distance ≤260 µm was the corresponding cut-off value for a resolved malapposed strut after first-generation DES with a sensitivity of 89.3% and a specificity of 83.7% (SES: S--V distance ≤280 µm; PES: S--V distance ≤260 µm); (iv) the incidence of late-acquired malapposition and thrombus were relatively high (late-acquired malapposition: 7/40 stents; 17.5%; thrombus 8/40 stents: 20%); (v) most cases of thrombus, tissue prolapse, and minor dissection detected immediately after PCI were resolved during the follow-up period.

Stent malapposition {#s4a}
-------------------

Ako *et al*.^[@JES299C8]^ reported that the incidence of post-procedural stent malapposition was 16.3% in the IVUS analysis of SES in De Novo Coronary Lesions (SIRIUS) trial. In the IVUS analysis of the Taxus II study, the incidence of post-procedural stent malapposition was reported to be 11.5% for slow-release and 2.6% for moderate-release PES.^[@JES299C9]^ In the present study, malapposed struts were detected by post-procedural OCT in \>50% of enrolled stents, which was more frequent than expected based on these previous IVUS studies. Also, although still controversial, previous IVUS studies implied a possible link between late stent malapposition (persistent or late-acquired malapposition) and an increased risk for stent thrombosis.^[@JES299C10]--[@JES299C12]^ Therefore, it is important to identify the natural course of post-procedural malapposed struts to maximize the potential benefit and cost-effectiveness of performing additional procedures for stent optimization by avoiding unnecessary post-stent balloon dilation.

Despite a relatively high incidence of stents with at least one malapposed struts, the frequency and extent of malapposed struts appeared to be low. The average incidence of malapposed struts per stent was \<1% (0.6 ± 1.2%) and the average S--V distance was only 224 ± 71 μm. Additionally, among a total of 431 malapposed struts observed on post-procedural OCT images, \>85% of such struts (382 struts) resolved spontaneously during the follow-up period. Therefore, we speculate that additional interventional treatment for stent optimization might not be necessary for stents with minor malapposed struts with an S--V distance ≤260 μm after first-generation DES.

Although various factors may be associated with the healing process of malapposed struts (e.g. patient and lesion characteristics, procedural factors, type of stents used, etc), we speculate that the S--V distance at the index procedure and the extent of subsequent neointima proliferation are the most relevant factors for the healing process of malapposed struts. Indeed, the S--V distance of persistent malapposed struts was significantly greater than that of resolved malapposed struts. Additionally, the mean neointimal thickness of resolved malapposed struts was significantly greater than that of persistent and late-acquired malapposed struts, suggesting that increased neointimal proliferation might decrease the incidence of persistent and/or late-acquired malapposed struts through its proliferative healing process, enough to 'fill in' the space between the stents and the vessel wall. Our findings might support this speculation. Gutiérrez-Chico *et al*.^[@JES299C13]^ suggested a different healing mechanism in which the neointima progresses over time to cover the remaining malapposed struts. In our study, neointimal coverage represented as a bridge or partial bridge pattern by Gutiérrez-Chico *et al*.^[@JES299C13]^ may have been misclassified as thrombus formation. Also, a previous report demonstrated that stent design and drug release kinetics are important factors for stent strut coverage.^[@JES299C14]^ Everolimus-eluting and zotarolimus-eluting stents were used these previous studies, and the progression pattern of neointima may differ depending on the stent type.

A recent report suggested that larger acute stent malapposition might be responsible for persistent malapposition and delayed neointimal coverage.^[@JES299C13]^ Our study demonstrated the cut-off value of the S--V distance between resolved and persistent malapposition, and the high rate of incomplete neointimal coverage in cases with persistent malapposition (\>80%). The size of acute stent malapposition after PCI can be estimated by various parameters. Among them, S--V distance can be measured directly and easily by OCT. We suggest that S--V distance is an easy-to-use parameter for decision-making at the time of PCI.

In our study, the relationship between malapposition and late stent thrombosis was not clear. Guagliumi *et al*.^[@JES299C15]^ reported an association between late stent thrombosis and OCT evidence of an increased frequency and length of uncovered and malapposed strut. Moreover, they suggested that late-acquired stent malapposition and extensive vessel remodelling are markers of underlying vascular toxicity and inflammation, the actual likely cause of stent thrombosis. We also found a high rate of incomplete neointimal coverage on the late-acquired malapposed struts and on the persistent malapposed struts. The uncovered and malapposed struts at the mid-term follow-up might persist for several years and thus cause late stent thrombosis.

Although our study excluded malapposed side-branch struts from OCT analysis, the first human *in vivo* study addressing the coverage of these struts was reported by Gutiérrez-Chico *et al*.^[@JES299C16]^ They demonstrated coverage of malapposed side-branch struts is delayed with respect to well-apposed struts in drug-eluting stents.

Comparison of S--V distance between SES and PES {#s4b}
-----------------------------------------------

We identified different cut-off values for predicting the natural course of malapposed struts between SES and PES in this study. Although previous reports have consistently demonstrated greater neointimal proliferation with PES than with SES,^[@JES299C17]^ our results indicated a longer cut-off S--V distance for SES than for PES. We speculate that this is mainly due to the difference in strut thickness between SES and PES (Cypher™ SES: 140 µm, Taxus Liberte™ PES: 97 µm). Even in cases with the same S--V distance, a thicker SES strut might lead to a shorter distance from abluminal side of the strut to the vessel, so that post-procedural malapposition is more likely to become well apposed during the follow-up.

In addition to the different cut-off S--V distance, a different predicting accuracy of S--V distance was observed between the two stent types. SES showed a greater AUC than PES in the ROC analysis, suggesting that S--V distance is more accurately predictive of the time course of post-procedural malapposition for SES than for PES. Although speculative, we consider that this can be partially explained by non-uniform vessel healing with PES when compared with SES.^[@JES299C17],[@JES299C18]^ In PES, even malapposed struts with a long S--V distance (e.g. \>260 μm) could resolve due to unexpectedly greater neointimal proliferation. On the other hand, malapposed struts with a short S--V distance (e.g. ≤260 μm) might persist due to extremely suppressed neointimal proliferation. The relatively uniform neointimal proliferation of SES might explain the more accurate prediction of the S--V distance for the time course of post-procedural malapposed struts.

Thrombus {#s4c}
--------

In the present study, a considerable incidence of thrombus attachment (15/40 stents: 37.5%) was observed immediately after stenting. This might be due to procedural problems, such as a longer time required to locate the stent or insufficient heparinization during PCI. Interestingly, serial OCT examination demonstrated that most cases of such thrombus, however, had disappeared at the 8-month follow-up examination (14/15 stents: 93%). On the other hand, despite dual antiplatelet therapy, late-acquired thrombus was observed in eight stents (8/40 stents: 20.0%) at the 8-month follow-up. Subclinical thrombus attachment after DES implantation has been reported in previous OCT and angioscopic reports.^[@JES299C5],[@JES299C19]^ According to such reports, the incidence of thrombus at mid-term follow-up OCT was 20--30% after first-generation DES, which is consistent with our results. Although the clinical impact of such thrombus remains unclear, there is concern regarding a possible link between subclinical thrombus attachment and DES restenosis or stent thrombosis.

A recent OCT study reported a significant association between late stent malapposition and the development of OCT-detected thrombus at the follow-up.^[@JES299C20]^ The present study also revealed a case in which a thrombus was present on malapposed struts at the follow-up (*Figure [7](#JES299F7){ref-type="fig"}*). Figure 7A representative case of thrombus with late stent malapposition.

In a previous OCT study, we reported a possible association between stent eccentricity and thrombus formation after SES implantation. Additionally, the cytochrome P450 2C19\*2 polymorphism is associated with subclinical OCT-detectable thrombus in patients treated with SES.^[@JES299C21]^ On the basis of these previous findings, we speculate that the mechanism of thrombus formation involves multiple factors, including patient, lesion, and procedural factors. A larger study is necessary to confirm our speculation.

Tissue prolapse and stent edge dissection {#s4d}
-----------------------------------------

In a post-mortem study, compression of the coronary plaque after stent implantation with the protrusion of tissue between the struts was observed in 94% of the patients.^[@JES299C22]^ This finding is in agreement with our study in which tissue prolapse between the struts was visible in the vast majority of enrolled stents (95%: 38/40 stents). In a previous IVUS study, minor plaque prolapse was not associated with late angiographic in-stent restenosis.^[@JES299C23]^ In our study, OCT-detectable tissue prolapse immediately after PCI was not correlated with restenosis at the follow-up. With regard to stent edge dissection, Hong *et al*.^[@JES299C24]^ reported that non-flow-limiting edge dissections detected by IVUS are not associated with an increase in acute or long-term clinical events. In our study, none of the cases with stent edge dissection on OCT images had restenosis and all of such dissections healed spontaneously during the follow-up. On the basis of these findings, we suggest that non-flow-limiting tissue prolapse and edge dissection might not require further intervention.

Clinical significance of minor abnormalities {#s4e}
--------------------------------------------

The present OCT study investigated the natural course of minor abnormalities after stenting during the 8-month follow-up periods. These findings were not associated with an adverse clinical outcome. Our study suggested that these abnormalities might be benign phenomenon. Previous reports provided this information, and our result also supported their studies.^[@JES299C20],[@JES299C25]^

Limitation {#s4f}
----------

Our study has a number of limitations. First, this is a non-randomized retrospective study based on a relatively limited sample size, raising the possibility of selection bias. Secondly, although we carefully reviewed both post-stenting and follow-up OCT images, it is sometimes difficult to completely match the lesions on the post-stenting and follow-up OCT images. Thirdly, although OCT is a high-resolution modality, it may not be able to differentiate neointima from an organized white thrombus, as both show high backscatter on the image. The smooth shape thrombus might thus be misdiagnosed as neointima. Fourthly, the cut-off value obtained by ROC curve analysis may be specific for the parameters of our study design, such as follow-up duration, stent design, and strut thickness with a limited number of lesions. Fifthly, strut-based analysis was performed at every frame interval. Stent-based analysis by our methodology equally evaluates stents with a single-malapposed strut as well as stents with large sections of malapposed struts. This methodology is different from that of previous IVUS studies, and the results of the present study might not be directly comparable. Finally, although we investigated the association between the minor abnormalities and the mid-term clinical event, this study is not sufficiently powered to detect possible association between them. A larger study with a longer-term follow-up will be warranted.

Conclusion {#s5}
==========

Most cases of minor stent malapposition, thrombus, tissue prolapse, and edge dissection after stenting improved spontaneously during the follow-up period. Thus, these minor abnormalities observed immediately after PCI may not require additional interventional treatment. OCT has a potential to provide information for a specific recommendation regarding the optimal endpoint for stent implantation in daily clinical practice.
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[^1]: Values are presented as number of patients (%).

[^2]: PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting, ACE, angiotensin-converting enzyme, ARB, angiotensin II receptor blocker.

[^3]: Values are presented as mean ± SD or number of stents.

[^4]: ACC, American College of Cardiology; AHA, American Heart Association.
